Universal Health(DE:UHS)
€176.00-1.00 (-0.56%)
DE:UHS
Universal Health stock forecast
€176.00
At close:-1.00 (-0.56%)
Universal Health (UHS) Stock Forecast & Price Target
3 Followers
UHS Analyst Ratings
Hold
5Buy10Hold1Sell
Based on 16 analysts giving stock ratings to Universal Health in the past 3 months
UHS Stock 12 Month Forecast
Average Price Target
€177.23▲(0.70% Upside)Based on 16 Wall Street analysts offering 12 month price targets for Universal Health in the last 3 months. The average price target is EUR 177.23 with a high forecast of EUR 225.29 and a low forecast of EUR 140.58. The average price target represents a 0.70% change from the last price of EUR 176.00.
Past 12 Months12 Month ForecastJan2026Oct2026
High€225.29
Average€177.23
Low€140.58
Highest Price TargetHighest€225.29Average Price Target€177.23Lowest Price TargetLowest€140.58
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Ann Hynes | Mizuho Securities | €180.24→€202.77 | buy | 15.21%Upside | Reiterated | 11/11/26 | ||
| Sarah James | Cantor Fitzgerald | ― | hold | ― | Reiterated | 11/11/26 | ||
| Ben Hendrix | RBC Capital | €164.92→€186.54 | hold | 5.99%Upside | Reiterated | 11/10/26 | ||
| Scott Fidel | Goldman Sachs | €171.22 | hold | -2.71%Downside | Reiterated | 11/09/26 | ||
| Kevin Fischbeck | Bank of America Securities | ― | sell | ― | Reiterated | 11/05/26 | ||
| Stephen Baxter | Wells Fargo | €149.60→€153.20 | hold | -12.95%Downside | Assigned | 11/02/26 | ||
| A.J. Rice | UBS | €261.34→€225.29 | buy | 28.01%Upside | Reiterated | 10/30/26 | ||
| Craig Hettenbach | Morgan Stanley | €172.13 | hold | -2.20%Downside | Assigned | 10/29/26 | ||
| Matthew Gillmor CFA | KeyBanc | ― | hold | ― | Reiterated | 10/29/26 | ||
| Michael Ha | Robert W. Baird | €149.60→€140.58 | hold | -20.12%Downside | Reiterated | 10/29/26 | ||
| Ryan Langston | TD Cowen | €177.53 | buy | 0.87%Upside | Reiterated | 10/29/26 | ||
| Andrew Mok CFA | Barclays | €151.40 | hold | -13.98%Downside | Reiterated | 10/28/26 | ||
| Jason Cassorla | Guggenheim | €188.35→€181.14 | buy | 2.92%Upside | Reiterated | 10/28/26 | ||
| John Ransom | Raymond James | ― | hold | ― | Reiterated | 09/28/26 | ||
| Whit Mayo | Leerink Partners | €178.43→€184.74 | buy | 4.97%Upside | Reiterated | 09/18/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Ann HynesMizuho Securities | BuyReiterated€180.24→€202.77 | 11/11/26 | 15.21%Upside | ||
| Sarah JamesCantor Fitzgerald | HoldReiterated | 11/11/26 | ― | ||
| Ben HendrixRBC Capital | HoldReiterated€164.92→€186.54 | 11/10/26 | 5.99%Upside | ||
| Scott FidelGoldman Sachs | HoldReiterated€171.22 | 11/09/26 | -2.71%Downside | ||
| Kevin FischbeckBank of America Securities | SellReiterated | 11/05/26 | ― | ||
| Stephen BaxterWells Fargo | HoldAssigned€149.60→€153.20 | 11/02/26 | -12.95%Downside | ||
| A.J. RiceUBS | BuyReiterated€261.34→€225.29 | 10/30/26 | 28.01%Upside | ||
| Craig HettenbachMorgan Stanley | HoldAssigned€172.13 | 10/29/26 | -2.20%Downside | ||
| Matthew Gillmor CFAKeyBanc | HoldReiterated | 10/29/26 | ― | ||
| Michael HaRobert W. Baird | HoldReiterated€149.60→€140.58 | 10/29/26 | -20.12%Downside | ||
| Ryan LangstonTD Cowen | BuyReiterated€177.53 | 10/29/26 | 0.87%Upside | ||
| Andrew Mok CFABarclays | HoldReiterated€151.40 | 10/28/26 | -13.98%Downside | ||
| Jason CassorlaGuggenheim | BuyReiterated€188.35→€181.14 | 10/28/26 | 2.92%Upside | ||
| John RansomRaymond James | HoldReiterated | 09/28/26 | ― | ||
| Whit MayoLeerink Partners | BuyReiterated€178.43→€184.74 | 09/18/26 | 4.97%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Universal Health
3 Months
Success Rate22/32 ratings generated profit
69%
Average Return
+4.72%
Copying Whit Mayo's trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +4.72% per trade.
1 Year
Success Rate20/27 ratings generated profit
74%
Average Return
+12.91%
Copying Ann Hynes's trades and holding each position for 1 Year would result in 74.07% of your transactions generating a profit, with an average return of +12.91% per trade.
2 Years
Success Rate22/27 ratings generated profit
81%
Average Return
+26.63%
Copying Ann Hynes's trades and holding each position for 2 Years would result in 81.48% of your transactions generating a profit, with an average return of +26.63% per trade.
UHS Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 2 | 0 |
| Buy | 5 | 5 | 5 | 4 | 5 |
| Hold | 13 | 12 | 15 | 13 | 14 |
| Sell | 4 | 4 | 3 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 24 | 24 | 26 | 21 | 21 |
In the current month, UHS has received 5 Buy Ratings, 14 Hold Ratings, and 2 Sell Ratings. UHS average Analyst price target in the past 3 months is 177.23.
UHS Financial Forecast
High€5.45
Consensus€5.04
Low€4.39
UHS Earnings Forecast
Next quarter’s earnings estimate for UHS is EUR 5.04 with a range of EUR 4.39 to EUR 5.45. The previous quarter’s EPS was EUR 4.67. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€4.34B
Consensus€4.25B
Low€4.16B
UHS Sales Forecast
Next quarter’s sales forecast for UHS is EUR 4.25B with a range of EUR 4.16B to EUR 4.34B. The previous quarter’s sales results were EUR 4.24B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
UHS Stock Forecast FAQ
What is DE:UHS’s average 12-month price target, according to analysts?
Based on analyst ratings, Universal Health’s 12-month average price target is €177.23.
What is DE:UHS’s upside potential, based on the analysts’ average price target?
Universal Health has 0.70% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Universal Health a Buy, Sell or Hold?
Universal Health has a consensus rating of Hold, which is based on 5 buy ratings, 10 hold ratings and 1 sell ratings.
What is Universal Health’s share price target?
The average share price target for Universal Health is €177.23. This is based on 16 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €225.29, and the lowest forecast is €140.58. The average share price target represents a 0.70% increase from the current price of €176.
What do analysts say about Universal Health?
Universal Health’s analyst rating consensus is a Hold. This is based on the ratings of 16 Wall Street analysts.
How can I buy shares of Universal Health?
To buy shares of DE:UHS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
